Department of Urology (c/o Mr Raj Nigam), Royal Surrey County Hospital, Egerton Road, Guildford, Surrey, GU2 7XX, UK.
World J Urol. 2019 Feb;37(2):337-342. doi: 10.1007/s00345-018-2390-8. Epub 2018 Jul 4.
Multi-parametric MRI (MP-MRI) prior to prostate biopsy is the investigation of choice for an elevated age-related PSA and abnormal digital rectal examination. MP-MRI in combination with transperineal template mapping biopsy has facilitated the development of the concept of targeted biopsies, either cognitively or with software fusion. Urinary retention is a recognised complication of transperineal prostate biopsy, with reported incidence being 1.6-11.4%. We present patient and procedure-related factors, which influence occurrence of urinary retention after transperineal template biopsy.
Retrospective data collection of 243 consecutive cases of transperineal template biopsies performed at a single institution were recorded and analysed. Biopsies were taken using a standard 5-mm template in 4-6 sectors, depending on the prostate volume.
31/243 (12.8%) patients developed urinary retention, defined as patient discomfort and inability to micturate and bladder scan of ≥ 600 ml. Patients in the retention group were significantly older (mean 68.7 vs. 65.8 years, P = 0.034). Prostate volume was significantly greater in comparison with the non-retention group (mean 75.4 vs. 57.2 cc, P = 0.0016). The number of biopsies taken was positively correlated with urinary retention (median 35 vs. 32 biopsies, P = 0.045), and this was independent of prostate size (R = 0.2). Presenting PSA, pre-operative flow and histopathological outcome were independent of urinary retention.
Factors resulting in an increased risk of urinary retention are advancing age (> 68.7 years); a larger prostate volume (> 75 cc); greater number of biopsies (> 35); greater severity of lower urinary tract symptoms prior to biopsy and diabetes. Targeted biopsies alone, instead of a full template, may avoid urinary retention in the high-risk groups identified.
在前列腺活检前进行多参数 MRI(MP-MRI)是针对年龄相关 PSA 升高和直肠指诊异常的首选检查方法。MP-MRI 结合经会阴模板定位活检促进了靶向活检概念的发展,无论是通过认知还是软件融合。尿潴留是经会阴前列腺活检的一种公认的并发症,其报告发病率为 1.6-11.4%。我们介绍了影响经会阴模板活检后尿潴留发生的患者和手术相关因素。
对一家医疗机构进行的 243 例连续经会阴模板活检的回顾性数据进行了收集和分析。活检采用标准的 5mm 模板,根据前列腺体积在 4-6 个部位进行取样。
243 例患者中有 31 例(12.8%)发生尿潴留,定义为患者不适、无法排尿和膀胱扫描≥600ml。在潴留组中,患者年龄明显更大(平均 68.7 岁 vs. 65.8 岁,P=0.034)。与非潴留组相比,前列腺体积明显更大(平均 75.4 毫升 vs. 57.2 毫升,P=0.0016)。活检次数与尿潴留呈正相关(中位数 35 次 vs. 32 次活检,P=0.045),与前列腺大小无关(R=0.2)。术前 PSA、术前尿流率和组织病理学结果与尿潴留无关。
导致尿潴留风险增加的因素包括年龄较大(>68.7 岁);前列腺体积较大(>75 毫升);活检次数较多(>35 次);活检前下尿路症状较严重和患有糖尿病。在确定的高危人群中,仅进行靶向活检而不是完整模板活检可能避免尿潴留。